Sorry, I don’t realise you were the investor relations contact at Mesoblast. I have been invested in this company since 2015 and have been patiently riding the highs and lows.
My views come from someone who works in healthcare and believes in the science and have stated that many a times.
The concerns I have are the financial health of the
company. If you think for one second that management has done a great job at negotiating partnership deals (leaving the FDA out of it as I don’t have time for them either) then you keep increasing those holdings of yours and I’ll “get out of your way”.
I’m not an incessant poster like some. When I post I try and be impartial as much as possible, with a more positive bias as I have been a LTH.
So please feel free to post whatever you like, but don’t come and school me on what I should and shouldn’t do. We all invest as per our strategy. I genuinely want Mesoblast to succeed, I just have concerns on whether the company will be in a strong financial position to support the great product!
GLTAH
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-380
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
96.5¢ | 96.5¢ | 94.5¢ | $2.433M | 2.552M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 94.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 20225 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 0.945 |
6 | 52140 | 0.940 |
8 | 92185 | 0.935 |
5 | 73150 | 0.930 |
4 | 51132 | 0.925 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 20225 | 5 |
0.955 | 42472 | 3 |
0.960 | 80775 | 4 |
0.965 | 57967 | 5 |
0.970 | 73641 | 5 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online